Skip to content

ALS Society of Canada

A Canadian voluntary health organization supporting people affected by amyotrophic lateral sclerosis, provincial ALS societies, research, and public awareness.

Last updated August 26, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

The ALS Society of Canada, commonly referred to as ALS Canada, is a Canadian voluntary health organization dedicated to improving the lives of people affected by amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Established in 1977, it operates as a registered not-for-profit organization and works nationally through partnerships with provincial ALS societies, researchers, clinicians, donors, volunteers, and people living with ALS. ALS Canada’s work is organized around three closely connected purposes. First, it supports research intended to explain the causes of ALS, improve treatment, and ultimately find a cure. Second, it supports provincial ALS organizations that provide direct services to people living with the disease, their families, and caregivers. Third, it raises public awareness of ALS and advocates for improved recognition of the needs of affected individuals and communities. The organization does not function primarily as a commercial product brand. Its public-facing identity is associated with charitable fundraising, research investment, information resources, advocacy, and coordination across Canada’s ALS support system. Provincial societies and their local chapters provide many front-line services, including information and referrals, support groups, equipment programs, and assistance for people with ALS, families, physicians, and other health-care providers. ALS Canada’s national role is therefore collaborative: it helps strengthen the broader network rather than replacing provincial delivery organizations. Research has been a central part of ALS Canada’s mandate. Since 2000, the organization has participated in the Neuromuscular Research Partnership, alongside the Canadian Institutes of Health Research and Muscular Dystrophy Canada. Through this partnership, grants support research into neuromuscular disease causes, treatments, and potential cures. ALS Canada has also supported a national clinical trial examining whether lithium could slow disease progression in people with early-stage ALS. The trial involved the Canadian ALS Clinical Trials and Research Network and represented a collaboration with the Northeastern ALS Consortium in the United States. The available reference material identifies this as ALS Canada’s largest research investment at the time, but does not establish a current financial figure or trial outcome. Public education and fundraising are another major part of the organization’s identity. June is recognized as ALS Awareness Month in Canada, and activities conducted by ALS Canada and provincial partners include fundraising walks, golf tournaments, community events, and the planting of blue cornflowers, which are associated with ALS Canada. The WALK for ALS has taken place in communities across the country and helps connect awareness-building with financial support for services and research. ALS Canada has also developed targeted educational initiatives. In 2006 it launched als411, an initiative designed to help children and teenagers cope when ALS affects someone in their family. A related bilingual website was developed in 2008, with distinct resources for younger children and teens. These resources included age-appropriate information, personal stories, coping material, interactive features, and links to social networking resources for teenagers. The organization’s communications have included bilingual English- and French-language public service advertising. In 2008, ALS Canada introduced a campaign comprising television advertisements titled “Head and Shoulders” and print advertisements titled “No Signal.” The campaign sought to explain ALS and increase general public awareness of the disease. Overall, ALS Society of Canada’s positioning combines national coordination, charitable health support, disease education, research funding, and advocacy for Canadians affected by ALS.

History

The ALS Society of Canada was founded in 1977 as a national voluntary health organization serving Canadians affected by amyotrophic lateral sclerosis. Its development reflected the need for a coordinated national response to a disease that requires medical, equipment, social, informational, and family support, while also demanding sustained investment in research. From its national base, ALS Canada developed a collaborative relationship with provincial ALS societies. These provincial organizations established or supported local chapters and support groups and delivered direct assistance to people living with ALS, their families, and caregivers. Their services included information and referrals, equipment programs, and support for people affected by ALS as well as physicians and other health-care professionals. ALS Canada’s role has been to support and connect this provincial network, promote consistent attention to the needs of the ALS community, and represent national priorities in research, awareness, and advocacy. Research became a defining element of the organization’s mission. In 2000, ALS Canada joined the Neuromuscular Research Partnership, a collaboration involving the Canadian Institutes of Health Research and Muscular Dystrophy Canada. The partnership created a mechanism for research grants addressing the causes, treatment, and eventual cure of neuromuscular disorders. ALS Canada later supported a national clinical trial studying lithium as a possible way to slow ALS progression in people with early-stage disease. The trial brought together Canadian ALS clinicians through the Canadian ALS Clinical Trials and Research Network and represented the first joint effort between that network and the Northeastern ALS Consortium in the United States, according to the referenced account. The organization also expanded its work in public communication and community engagement. June became an important period for ALS awareness in Canada, with ALS Canada and provincial societies organizing walks, golf tournaments, and other fundraising and educational activities. The WALK for ALS developed as a multi-community event, while the blue cornflower became associated with the organization’s awareness work. These activities combine public education with fundraising for research and services. ALS Canada increasingly recognized the specific needs of children and teenagers whose families were affected by ALS. In 2006 it launched als411, an initiative intended to give young people understandable information and coping support. In 2008, the initiative was developed into a bilingual website with separate areas for younger children and teenagers in English and French. The resources included interactive features, personal stories, age-appropriate explanations, additional information, and social networking links for teen users. The same period saw a stronger emphasis on mass public awareness. In 2008, ALS Canada introduced bilingual television and print public service advertising. The television spots, titled “Head and Shoulders,” and the print advertisements, titled “No Signal,” were designed to help the wider public understand ALS and its impact. Today, ALS Society of Canada remains an active Canadian not-for-profit organization whose work spans research funding, coordination with provincial ALS societies, awareness, fundraising, education, and advocacy. Its identity is best understood as a national health-charity and support-network brand rather than a commercial consumer brand. The organization’s national programs complement direct provincial services and seek to advance both immediate support and long-term progress toward effective treatments and a cure.

  • 2008

    Creates bilingual als411 website

    [1]

    Separate English and French online resources are developed for younger children and teenagers, with educational and coping content.

  • 2008

    Introduces public service advertising campaign

    [1]

    The “Head and Shoulders” television spots and “No Signal” print advertisements are launched to increase awareness of ALS.

  • 2006

    Launches als411

    [1]

    The organization introduces an initiative to help children and teenagers cope with ALS in their families.

  • 2000

    Joins the Neuromuscular Research Partnership

    [1]

    ALS Canada becomes a partner in a research collaboration with the Canadian Institutes of Health Research and Muscular Dystrophy Canada.

  • 1977

    ALS Society of Canada is founded

    [1]

    The national voluntary health organization is established to support people affected by ALS, advance research, and build awareness in Canada.

Products and positioning

A national Canadian not-for-profit organization focused on ALS research, public awareness, advocacy, and support for the provincial organizations that serve people living with ALS and their families.

  • Research program

    ALS research funding

    ALS Canada funds and supports research into the causes, treatment, and cure of amyotrophic lateral sclerosis. Its research role includes participation in the Neuromuscular Research Partnership and support for national clinical research involving Canadian ALS investigators.

  • Support network

    Support for provincial ALS societies

    ALS Canada works with provincial ALS societies that provide local support groups, information and referrals, equipment programs, and assistance to people with ALS, families, caregivers, physicians, and other health-care providers.

  • Fundraising and awareness event

    WALK for ALS

    WALK for ALS is a community-based fundraising and awareness program conducted across Canada through ALS Canada and provincial partners. The available reference describes participation in more than 78 communities, but does not specify a current number of locations.

  • Youth information and support resource · 2006

    als411

    als411 provides age-appropriate information and coping resources for children and teenagers who have a family member affected by ALS. Its bilingual online format includes separate areas for younger children and teens, personal stories, interactive content, and additional resources.

Marketing campaigns

  • 2008Head and Shoulders / No Signal

    Canada

    ALS Canada launched a bilingual public service campaign consisting of two television spots, titled “Head and Shoulders,” and three print advertisements, titled “No Signal.” The campaign aimed to educate the general public about ALS and its impact.

  • WALK for ALS

    Canada

    A national awareness and fundraising program conducted in communities across Canada by ALS Canada and provincial ALS organizations.

  • ALS Awareness Month

    Canada

    June awareness activities include community fundraising events, public education, and symbolic support such as planting blue cornflowers associated with ALS Canada.

Brand decisions

  • 2008

    Increase national public awareness through bilingual advertisingOther

    Background

    ALS Canada identified public understanding of ALS as a key organizational priority.

    Action taken

    The organization launched the “Head and Shoulders” television spots and “No Signal” print advertisements in English and French.

    Aftermath

    The campaign provided a national public-service platform for explaining ALS and its consequences, although the available source does not report measured campaign results.

  • 2006

    Launch als411 youth-support initiativeProduct launch

    Background

    Children and teenagers may require specialized explanations and coping support when ALS affects a member of their family.

    Action taken

    ALS Canada launched als411 as a resource for younger people affected by ALS in their families.

    Aftermath

    The initiative was subsequently developed into bilingual online resources with separate content for children and teenagers.

  • 2000

    Expand collaborative neuromuscular research fundingStrategy

    Background

    ALS Canada sought to advance its research mission through cooperation with national health-research and neuromuscular-disease organizations.

    Action taken

    It joined the Neuromuscular Research Partnership with the Canadian Institutes of Health Research and Muscular Dystrophy Canada.

    Aftermath

    The partnership provided a framework for grants addressing neuromuscular disease causes, treatments, and potential cures.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/als-society-of-canada · Editorial policy · How profiles are compiled